An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on an online forum asked whether it’s a good idea to combine shockwave therapy (a clinic treatment that uses sound waves) with two experimental peptides—TB500 and BPC-157—to treat long-term sit-bone pain and plantar fasciitis. They said they’ve had these problems for about four years, are already getting shockwave therapy from a podiatrist, and want to know if others have experience stacking the peptides with the treatment. TB500 and BPC-157 are short chains of amino acids that people talk about online as “healing” peptides. TB500 is a lab-made fragment related to a natural protein called thymosin beta-4; proponents say it may help tissue repair and reduce inflammation. BPC-157 is a small peptide derived from a protein found in stomach juice and is also claimed to help tendon and ligament healing. Neither is an approved prescription drug for these conditions; most human data are very limited and much of the buzz comes from animal studies, lab work, or anecdotal reports. The post is not a research study — it’s a patient asking for other people’s experiences. That means there’s no controlled data here showing whether combining shockwave therapy with TB500 or BPC-157 helps or harms. In medical research, what matters are randomized trials in people; for these peptides those trials are scarce or absent for musculoskeletal uses. There are some animal studies and plenty of personal stories online that suggest possible benefits, but those don’t reliably prove anything about safety or effectiveness in humans. Shockwave therapy itself has some evidence for chronic plantar fasciitis and certain tendon problems, but effects vary by protocol and patient. Why this question matters is practical: chronic sit-bone pain and plantar fasciitis can be stubborn and disabling. People who haven’t improved with standard approaches look for additional options. If a peptide actually helped tissue repair, combining it with a clinic procedure might make intuitive sense. Also, people often consider “stacking” treatments to try to speed recovery, so understanding what’s known (and not known) helps someone make a safer choice. If you’re considering anything like this, it’s worth discussing with the treating clinician so they can consider interactions, dosing, and realistic expectations. There are important caveats and risks. TB500 and BPC-157 are generally not regulated medicines, so product purity and dosing can be uncertain. Human safety data are limited; unknown side effects or long-term risks could exist. They could also complicate wound healing or interact with other conditions or medications. Shockwave therapy already has known side effects like temporary pain increase, bruising, or nerve irritation. Pregnant people, people with active infections, or those on certain medications should be cautious. Because credible clinical evidence is lacking, a conservative approach is to rely on proven therapies first and to only consider experimental peptides under medical supervision or in a research setting. Bottom line: the forum post is asking for anecdotes; there’s no solid human evidence that adding TB500 or BPC-157 to shockwave therapy helps, and there are real unknowns about safety and product quality.
Source: r/Peptides